Veracyte, Inc. (VCYT) — 8-K Filings

8-K Filings (16)

• Veracyte, Inc. Files 8-K on Financials — Nov 4, 2025 Risk: low
  Veracyte, Inc. filed an 8-K on November 4, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits
• Veracyte, Inc. Files 8-K on Financials — Aug 6, 2025 Risk: low
  On August 6, 2025, Veracyte, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fin
• Veracyte, Inc. Files 8-K on Corporate Governance and Financials — Jun 18, 2025 Risk: low
  Veracyte, Inc. filed an 8-K on June 17, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officer
• Veracyte, Inc. Files 8-K on Financials — May 7, 2025 Risk: low
  Veracyte, Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibit
• Veracyte, Inc. Files 8-K on Financials — Feb 24, 2025 Risk: low
  Veracyte, Inc. filed an 8-K on February 24, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits.
• Veracyte, Inc. Files 8-K for Operations Update — Nov 6, 2024 Risk: low
  Veracyte, Inc. filed an 8-K on November 6, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exh
• Veracyte Appoints New Directors, Adjusts Executive Compensation — Sep 4, 2024 Risk: low
  Veracyte, Inc. announced on September 3, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new directors
• Veracyte, Inc. Files 8-K on Financials — Aug 6, 2024 Risk: low
  On August 6, 2024, Veracyte, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements and
• Veracyte Appoints New CMO, Elects Directors — Jun 13, 2024 Risk: low
  Veracyte, Inc. announced on June 12, 2024, the appointment of Dr. Richard M. Klausner as Chief Medical Officer and the election of Dr. Klausner and Ms. Jennifer
• Veracyte, Inc. Files 8-K for Financials — May 7, 2024 Risk: low
  Veracyte, Inc. filed an 8-K on May 7, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits
• Veracyte Appoints New Director, Grants RSUs — Mar 22, 2024 Risk: low
  On March 22, 2024, Veracyte, Inc. filed an 8-K report detailing the appointment of Dr. Elna M. Johansson as a new Class II director, effective March 18, 2024. D
• Veracyte Files 8-K for 'Other Events' and Exhibits — Feb 29, 2024 Risk: low
  Veracyte, Inc. filed an 8-K on February 29, 2024, reporting 'Other Events' and 'Financial Statements and Exhibits'. The filing indicates no specific material ev
• Veracyte Files 8-K on Financial Condition and Operations — Feb 22, 2024 Risk: low
  VERACYTE, INC. filed an 8-K on February 22, 2024, reporting on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'. This fil
• Veracyte Files 8-K on Officer/Director Changes & Compensation — Feb 13, 2024 Risk: medium
  VERACYTE, INC. (CIK: 0001384101) filed an 8-K on February 13, 2024, reporting an event that occurred on February 7, 2024. The filing indicates changes related t
• VERACYTE REPORTS ASSET ACQUISITION & UNREGISTERED EQUITY SALE — Feb 6, 2024
  Veracyte, Inc. (VCYT) filed an 8-K on February 6, 2024, reporting an event that occurred on February 5, 2024, related to the completion of an acquisition or dis
• VERACYTE Files 8-K on Operations & Financial Condition — Jan 8, 2024
  Veracyte, Inc. filed an 8-K on January 8, 2024, to report on its results of operations and financial condition, as well as to make a Regulation FD disclosure. T

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX